Research paper most likely shows that benzodiazepines are used to treat early symptoms of dementia

BMJ (Online)

Volumn 345, Issue 7885, 2012, Pages

  Bocti, Christian ^a   Roy Desruisseaux, Jessika ^a   Roberge, Pasquale ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ANXIETY; ANXIETY DISORDER; ATTRIBUTABLE RISK; CLINICAL PRACTICE; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG EXPOSURE; DRUG UTILIZATION; FOLLOW UP; HUMAN; LETTER; LONGITUDINAL STUDY; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SLEEP DISORDER; SLEEP QUALITY;

BENZODIAZEPINES; DEMENTIA; FEMALE; HUMANS; MALE;

EID: 84870501763     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e7986     Document Type: Letter

References (5)

1. Billioti de Gage S, Bégaud B, Bazin F, Verdoux H, Dartigues J-F, Pérès K, et al. Benzodiazepine use and risk of dementia: prospective population based study. BMJ 2012;345:e6231. (27 September.)
2. Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs and Aging 2012;29:639-58.
3. Amieva H, Le Goff M, Millet X, Orgogozo JM, Peres K, Barberger-Gateau P, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol 2008;64:492-8.
4. Sliwinski MJ, Hofer SM, Hall C, Buschke H, Lipton RB. Modeling memory decline in older adults: the importance of preclinical dementia, attrition, and chronological age. Psychology and Aging 2003;18:658-71. (Pubitemid 37543429)
5. Reisberg B, Prichep L, Mosconi L, John ER, Glodzik-Sobanska L, et al. The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease. Alzheimer's and Dementia: the Journal of the Alzheimer's Association 2008;4:S98-108.